Form 4: Director Lewin Boosts ESTA Stake with Share Election

Establishment Labs Holdings Inc. Director Nicholas Sheridan Lewin acquired 609 common shares by electing to receive equity in lieu of a cash retainer.

Summary

• Nicholas Sheridan Lewin, a Director of Establishment Labs Holdings Inc. (ESTA), acquired 609 common shares.
• The acquisition occurred on September 30, 2025, at a price of $40.99 per share.
• These shares were received in lieu of a quarterly cash retainer payment, as per the Issuer's Outside Director Compensation Policy.
• The shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
• Following this transaction, Mr. Lewin directly beneficially owns 1,076,532 common shares and indirectly owns 19,090 common shares through his spouse.

Sentiment

Score: 7

Explanation: The director's decision to receive shares instead of cash indicates confidence in the company's future, which is a positive signal for investors. However, it's a routine compensation election rather than a significant open market purchase.

Positives

• Director Lewin's election to receive shares instead of cash indicates confidence in the company's future performance and aligns his interests with shareholders.
• The transaction increases the director's direct beneficial ownership in the company.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, but the director's election to receive equity suggests a positive long-term view on the company's prospects.

Management Comments

• Director Lewin elected to receive common shares in lieu of a quarterly cash retainer payment, aligning his compensation with shareholder interests.

Industry Context

This transaction is a routine insider filing, common for directors who opt to receive equity compensation, reflecting a standard practice in corporate governance to align management and director incentives with shareholder value creation. It does not provide broader industry insights.

Comparison to Industry Standards

• The practice of directors electing to receive equity in lieu of cash compensation is a common corporate governance mechanism across various industries, including medical technology, to foster alignment between director interests and shareholder value. While no specific comparable companies or projects are mentioned, this aligns with best practices for director compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through increased equity ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing.

Key Dates

Recommendation

This Form 4 filing indicates a routine insider transaction where a director elected to receive shares in lieu of cash compensation. While this signals confidence and aligns director interests with shareholders, it is not a significant open market purchase that would fundamentally alter the investment thesis. It reinforces a 'hold' position for investors who believe in the company's long-term strategy, as it doesn't present new information warranting a change in investment stance.

Keywords

Establishment Labs Holdings Inc., ESTA, Form 4, Insider Trading, Director Share Acquisition, Equity Incentive Plan, Nicholas Sheridan Lewin